A trial for an HIV vaccine was reportedly near termination but received a last-minute reprieve. However, it is unclear what prompted the reprieve or the current status of the trial, as reports of the incident are mixed with unrelated stories of death row inmates and other cases receiving last-minute reprieves. The focus of the HIV vaccine trial may be shifting to neutralizing antibodies, but details of the trial's future are unclear.